• Issue

    Clinical and Experimental Neuroimmunology: Volume 16, Issue 1

    1-84
    February 2025
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1-3
  • First Published: 20 February 2025

LETTER TO THE EDITOR

Response to: Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder

Ilya Kister,  Alla Wilson, 
  • Pages: 4-5
  • First Published: 10 July 2024

Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder

Takeshi Fujimoto,  Yasuhiro Maeda, 
  • Page: 6
  • First Published: 30 July 2024

ORIGINAL ARTICLE

Th17 pathway-related immune signatures in the pathobiology of myasthenia gravis: Integrating the roles of regulatory/effector cytokines and transcription factors

Nibu Varghese,  Madhu Nagappa,  Nikhitha Sreenivas,  Saikat Dey,  Thrinath Mullapudi,  Anagha Pettututhazhe Kuniyil,  Sumanth Shivaram,  Doniparthi V. Seshagiri,  Binu Valsalakumari Sreekumaran Nair,  Monojit Debnath, 
  • Pages: 7-18
  • First Published: 08 July 2024

REVIEW ARTICLE

Intensity of subarachnoid space inflammation corresponds to the evolution of vessel wall remodeling during the acute and chronic phases of bacterial meningitis

Vivig Shantha Kumar,  Vignarth Shantha Kumar,  Ruthvik Thaghalli Sunil Kumar, 
  • Pages: 19-29
  • First Published: 07 July 2024

CASE REPORT

Successful treatment with plasmapheresis of severe Bickerstaff brainstem encephalitis with high cerebrospinal fluid CXCL-10 levels after COVID-19 infection: A case report

Naoki Iijima,  Kenzo Sakurai,  Riyoko Ko,  Kenji Isahaya,  Yoshihisa Yamano, 
  • Pages: 30-34
  • First Published: 08 July 2024
Open Access

Longitudinal imaging for monitoring disease activity in late-onset Rasmussen's encephalitis during multimodal rehabilitation and immune therapy

Lucas C. Adam,  Lana Gilly,  Joerg Mueller,  Joerg Wissel,  Anatol Kivi, 
  • Pages: 35-41
  • First Published: 17 July 2024
Longitudinal imaging for monitoring disease activity in late-onset Rasmussen's encephalitis during multimodal rehabilitation and immune therapy

Multimodal immune therapy and supportive rehabilitation in late-onset Rasmussen's encephalitis patients result in clinical and imaging-based disease stabilization. Longitudinal magnetic resonance imaging is a feasible tool to monitor therapy response during immune therapy in late-onset Rasmussen's encephalitis patients.

EDITORIAL

Unmasking the muscle mysteries: Cutting-edge insights into inflammatory myopathies

Satoshi Yamashita, 
  • Pages: 42-43
  • First Published: 08 January 2025

INVITED REVIEW

Myositis-specific/associated autoantibodies as diagnostic keys and disease drivers

Satoshi Yamashita, 
  • Pages: 44-54
  • First Published: 19 November 2024

Update on pathology of inflammatory myopathy

Akinori Uruha,  Satoko Uruha, 
  • Pages: 55-63
  • First Published: 07 January 2025

Interferons in myositis: Pathogenesis and therapy

Nozomu Tawara, 
  • Pages: 64-71
  • First Published: 26 January 2025
Open Access

Muscle magnetic resonance imaging findings in patients with idiopathic inflammatory myopathies

Tadanori Hamano,  Tomoko Kamisawa,  Sayaka Sanada,  Kouji Hayashi, 
  • Pages: 72-83
  • First Published: 29 January 2025

ACKNOWLEDGMENT

A thank you note to our reviewers

  • Page: 84
  • First Published: 06 February 2025